EMEA-003166-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/0064/2023
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection/infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Purevax RCPCh FeLV
vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections
Cats
Date of authorisation:
Revision: 15
Last updated:
MedicineVeterinaryAuthorised
Purevax RCPCh
Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections
Cats
Date of authorisation:
Revision: 17
Last updated:
MedicineVeterinaryAuthorised
Purevax RCCh
vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections
Cats
Date of authorisation:
Revision: 8
Last updated:
MedicineVeterinaryLapsed